tiprankstipranks
Purple Biotech (PPBT)
NASDAQ:PPBT
Holding PPBT?
Track your performance easily

Purple Biotech (PPBT) Financial Statements

938 Followers

Purple Biotech Financial Overview

Purple Biotech's market cap is currently ―. The company's EPS TTM is $-8.942; its P/E ratio is -0.24; Purple Biotech is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -4.83M$ -3.50M$ -7.28M
EBITDA--$ -4.79M$ -3.45M$ -7.22M
Net Income Common Stockholders--$ -4.82M$ -3.54M$ -7.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.41M$ 31.68M$ 33.08M$ 36.02M$ 39.55M
Total Assets$ 44.30M$ 54.62M$ 58.54M$ 61.74M$ 66.29M
Total Debt$ 351.00K$ 515.00K$ 550.00K$ 594.00K$ 694.00K
Net Debt$ -15.06M$ -31.17M$ -32.53M$ -35.42M$ -38.85M
Total Liabilities$ 10.01M$ 7.52M$ 6.43M$ 6.08M$ 7.97M
Stockholders Equity$ 34.21M$ 46.91M$ 51.89M$ 55.41M$ 58.06M
Cash Flow-
Free Cash Flow--$ -3.63M$ -3.71M$ -5.42M
Operating Cash Flow--$ -3.62M$ -3.70M$ -5.20M
Investing Cash Flow--$ 177.00K$ -5.98M$ 17.72M
Financing Cash Flow--$ 569.00K$ 294.00K$ 162.00K
Currency in USD

Purple Biotech Earnings and Revenue History

Purple Biotech Debt to Assets

Purple Biotech Cash Flow

Purple Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis